
Centessa Pharmaceuticals plc
NASDAQ:CNTA
13.72 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income
| -235.757 | -151.085 | -216.207 | -381.854 | -10.663 | -5.061 |
Depreciation & Amortization
| 0.942 | 0.81 | 0.131 | 0.034 | 0 | 0.006 |
Deferred Income Tax
| 2.653 | -26.632 | -2.857 | -6.804 | 0 | 0.001 |
Stock Based Compensation
| 33.546 | 29.392 | 24.965 | 14.852 | 0.336 | 0.236 |
Change In Working Capital
| 22.102 | -18.858 | -2.831 | -5.378 | -0.489 | -1.006 |
Accounts Receivables
| 0 | 0 | -11.704 | -6.721 | 0 | 0 |
Inventory
| 0 | 0 | 11.704 | -4.157 | 0 | 0 |
Accounts Payables
| -4.585 | -2.733 | 6.351 | 4.157 | -0.049 | 0.855 |
Other Working Capital
| 26.687 | -16.125 | -9.182 | 1.343 | -0.44 | -1.861 |
Other Non Cash Items
| 34.459 | 6.031 | -3.747 | 257.846 | 0.186 | -0.001 |
Operating Cash Flow
| -142.055 | -160.342 | -200.546 | -136.142 | -10.63 | -5.825 |
Investing Activities: | ||||||
Investments In Property Plant And Equipment
| -0.034 | -0.169 | -1.137 | -0.186 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 63.434 | 0 | 0 |
Purchases Of Investments
| 31.301 | -264.91 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 138.075 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0.206 | -0 | 0 | 0 |
Investing Cash Flow
| 31.267 | -127.004 | -0.931 | 63.248 | 0 | 0 |
Financing Activities: | ||||||
Debt Repayment
| -0.762 | 0 | 0 | 73.93 | 1.361 | 3.831 |
Common Stock Issued
| 359.605 | 20.807 | 0.718 | 586.442 | 0.01 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | -0.012 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 5.909 | 0.31 | 0.457 | 586.138 | 0.001 | 5.174 |
Financing Cash Flow
| 364.752 | 21.117 | 0.457 | 660.068 | 1.362 | 9.005 |
Other Information: | ||||||
Effect Of Forex Changes On Cash
| 1.227 | 0.615 | -0.418 | 1.902 | -0.075 | 0.52 |
Net Change In Cash
| 255.191 | -265.614 | -201.438 | 590.079 | -9.343 | 3.7 |
Cash At End Of Period
| 383.221 | 128.03 | 393.644 | 595.082 | 7.227 | 16.57 |